NCT06722157 A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06635148 A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) Status RECRUITING Phase PHASE2
NCT06557460 A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) Status RECRUITING Phase PHASE2
NCT06510816 A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06394232 Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. Status RECRUITING Phase PHASE1/PHASE2
NCT06381596 Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration Status COMPLETED Phase NA
NCT06351657 Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression Status RECRUITING Phase N/A
NCT06164587 Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06161584 A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06087458 Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration Status RECRUITING Phase PHASE1/PHASE2
NCT06018558 Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06006585 A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy Status COMPLETED Phase PHASE1
NCT05963646 Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study Status COMPLETED Phase N/A
NCT05961332 COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy Status COMPLETED Phase NA
NCT05949593 Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05891275 Patients With Geographic Atrophy and Their Patient Journey in the United States (US) Status COMPLETED Phase N/A
NCT05811351 A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) Status COMPLETED Phase PHASE2
NCT05797896 Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study Status ACTIVE_NOT_RECRUITING Phase N/A